Autoimmune Diseases

Latest News

Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval

April 19th 2024

This approval is the second biosimilar approval for manufacturer Alvotech.

Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RA
Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RA

April 8th 2024

Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval
Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval

March 7th 2024

FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval
FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval

February 26th 2024

COVID-19 Vaccine Shows Reduced Effect in Patients With RA Receiving DMARDs
COVID-19 Vaccine Shows Reduced Effect in Patients With RA Receiving DMARDs

January 2nd 2024

Latest CME Events & Activities

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

June 27, 2024 | 1:00 PM & 7:00 PM ET

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Exploring Targeted Treatment Options for Hereditary Angioedema: Considerations for Pharmacists

1.0 Credit / Immunology

View More

Unveiling the Impact of Childhood Eczema: A Guide to Moderate-Severe Pediatric Atopic Dermatitis

1.0 Credit / Dermatology, Immunology

View More

Revolutionizing Pediatric Atopic Dermatitis Treatment With Targeted Biologics

1.0 Credit / Dermatology, Immunology

View More

Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intrav...

1.0 Credit / Immunology, Rare Diseases

View More

Maximizing the Potential of Biologics in Moderate to Severe Pediatric Atopic Dermatitis: The Expertise of the ...

1.0 Credit / Dermatology, Immunology

View More

Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment

1.5 Credits / Allergy, Immunology

View More

Best Practices for Optimizing Biologic Therapy Management for Moderate to Severe Atopic Dermatitis in Children

1.5 Credits / Dermatology, Immunology

View More

Integrating Biologic Therapy Into Clinical Practice for the Management of Eosinophilic Esophagitis

1.5 Credits / Gastroenterology, Immunology

View More

Emerging Biologic Therapy for the Management of Eosinophilic Esophagitis in Children

1.0 Credit / Gastroenterology, Immunology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Understanding the Burden of Eosinophilic Esophagitis in Children

1.0 Credit / Gastroenterology, Immunology

View More

The Expertise of the Specialty Pharmacist in Pediatric Eosinophilic Esophagitis

1.0 Credit / Gastroenterology, Immunology

View More

Optimizing Inflammatory Bowel Disease Treatment: A Pharmacist's Guide to Biologics and Monoclonal Antibodies

1.0 Credits / Gastroenterology, Immunology

View More

Navigating the Complexities of Biologic Therapy for Moderate to Severe Atopic Dermatitis in Children: The Impa...

1.5 Credit / Dermatology, Immunology

View More

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Kno...

1.5 Credits / Immunology, Allergy

View More

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.